Trials / Completed
CompletedNCT00534664
Phase I/II Study of Amplitude-Modulated Electromagnetic Fields in the Treatment of Advanced Hepatocellular Carcinoma
Phase II Study to Determine the Effectiveness of Intrabuccally Administered Amplitude-Modulated Electromagnetic Fields in the Treatment of Advanced Hepatocellular Carcinoma
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- University of Sao Paulo · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to investigate the safety and feasibility of treating patients with advanced hepatocellular carcinoma with a noninvasive device administering low level of amplitude-modulated electromagnetic fields.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TheraBionic device | Daily outpatient treatment with theraBionic device |
Timeline
- Start date
- 2005-10-01
- Completion
- 2007-02-01
- First posted
- 2007-09-26
- Last updated
- 2007-09-26
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT00534664. Inclusion in this directory is not an endorsement.